Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)

NCT02781584 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02781584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02781584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Proof of Concept, Open-Label Study Evaluating the Safety, Tolerability, and Efficacy of Regimens in Subjects With Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
June 13, 2016
Completion date
December 17, 2020
Enrollment
220 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver disease (nafld), nonalcoholic steatohepatitis (nash)